This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
Obesity affects nearly half of adults in the United States and is contributing substantially to a pandemic of obesity-associated chronic conditions such as type 2 diabetes, hypertension, and arthritis. The obesity-associated chronic condition pandemic is particularly severe in low-income, medically underserved, predominantly African-American areas in the southern United States. Little is known regarding the impact of geographic, income, and racial disparities in continuity of care on major health outcomes for patients with obesity-associated chronic conditions.
The aim of this study is to assess, among patients with obesity-associated chronic conditions, and within this group, patients with type 2 diabetes, (1) whether continuity of care is associated with lower overall and potentially preventable emergency department and hospital utilization, (2) the effect of geographic, income, and racial disparities on continuity of care and on health care utilization, (3) whether continuity of care particularly protects individuals at risk for disparities from adverse health outcomes, and (4) whether characteristics of health systems are associated with higher continuity of care and better outcomes.
Using 2015-2018 data from 4 practice-based research networks participating in the Southern Obesity and Diabetes Coalition, we will conduct a retrospective cohort analysis and distributed meta-analysis. Patients with obesity-associated chronic conditions and with type 2 diabetes will be assessed within each health system, following a standardized study protocol. The primary study outcomes are overall and preventable emergency department visits and hospitalizations. Continuity of care will be calculated at the facility level using a modified version of the Bice-Boxerman continuity of care index. Race will be assessed using electronic medical record data. Residence in a low-income area or a health professional shortage area respectively will be assessed by linking patient residence ZIP codes to the Centers for Medicare & Medicaid Services database.
In 4 regional health systems across Tennessee, Mississippi, Louisiana, and Arkansas, a total of 53 adult hospitals were included in the study. A total of 147,889 patients with obesity-associated chronic conditions who met study criteria were identified in these health systems, of which 45,453 patients met the type 2 diabetes criteria for inclusion. Results are expected by the end of 2020.
This study should reveal whether health system efforts to increase continuity of care for patients with obesity and diabetes have potential to improve outcomes and reduce costs. Analyzing disparities in continuity of care and their effect on major health outcomes can help demonstrate how to improve care and use of health care resources for vulnerable patients with obesity-associated chronic conditions, and within this group, patients with type 2 diabetes. Better understanding of the association between continuity and health care utilization for these vulnerable populations will contribute to the development of higher-value health systems in the southern United States.
DERR1-10.2196/20788
Obesity affects nearly half (40%) of adults in the United States [
Furthermore, the burdens of uncontrolled obesity-associated chronic conditions are rising nationwide, particularly in areas designated by the Human Resources and Services Administration as primary care health professional shortage areas of the southern United States [
There is a critical need to quantify the impact of geographic, income, and racial disparities on continuity of care and health care utilization and identify characteristics of health systems with higher continuity and lower health care utilization for patients with obesity-associated chronic conditions and type 2 diabetes. Effective population health improvement requires examining comprehensive data across health systems to look at variations in care. Such pragmatic research has the potential to translate best health systems practices across different communities in the southern United States.
This protocol aims to assess (1) whether outpatient continuity of care is associated with lower overall and potentially preventable emergency department and hospital utilization for patients with obesity-associated chronic conditions and with type 2 diabetes, respectively; (2) the effect of geographic, income, ethnic, and racial disparities on continuity of care and overall and potentially preventable emergency department and hospital utilization among patients with obesity-associated chronic conditions and with type 2 diabetes; (3) whether continuity of care particularly protects individuals with obesity-associated chronic conditions and with type 2 diabetes at risk for geographic, income, ethnic, and racial disparities from overall and potentially preventable hospital and emergency department utilization; and (4) the characteristics of health systems with higher continuity and lower health care utilization for vulnerable patients with obesity-associated chronic conditions and in the type 2 diabetes.
We hypothesize that continuity of care will protect vulnerable individuals with obesity-associated chronic conditions, and within that group, individuals with type 2 diabetes, from overall and potentially preventable emergency department and hospital utilization. Additionally, continuity of care will be associated with lower emergency department and hospital use for (1) African-American individuals compared with that of white individuals or other individuals, (2) patients residing in health professional shortage areas compared with that of patients not residing in health professional shortage areas, and (3) patients residing in low-income areas compared with that of patients not residing in low-income areas. We also hypothesize that health systems with (1) a higher proportion of primary care providers to total providers, (2) a higher proportion of ambulatory to total encounters, and (3) a greater geographic distribution of ambulatory care sites will experience lower levels of overall and potentially preventable emergency department and hospital use among patients receiving ambulatory care within the system.
We will conduct a retrospective cohort analysis and meta-analysis of all adult patients with obesity-associated chronic conditions—defined as patients who are obese (BMI≥30 kg/m2) and who have ≥1 additional diagnosed obesity-associated chronic condition (a list of the included conditions is available in
This study will be conducted separately at the following sites: (1) University of Tennessee Health Science Center, (2) University of Mississippi Medical Center, (3) Tulane Medical Center, and (4) Ochsner Health System. The data from all sites will be aggregated to conduct meta-analysis. Electronic medical records from between 2015 and 2018 including encounters from all adult emergency department, hospitals, and clinics will be utilized. The index visit will be defined as the first visit of any type occurring between January 1, 2016 and December 31, 2017. The baseline year will be defined as the first full year prior to the qualifying index visit date (as defined above) for which the full inclusion criteria are met. The baseline year will be used to identify adult patients with obesity-associated chronic conditions and type 2 diabetes seen 2 or more times for ambulatory care. Outcomes will be assessed in a 1-year period following the index visit. The study design is shown in
Study design.
The study will include patients with obesity-associated chronic conditions and with type 2 diabetes who meet the following criteria: patients aged >18 years at their index visit, who are obese (defined as BMI>30 kg/m2) at their index visit (if BMI>100 kg/m2, they will be excluded; if there are multiple valid BMI values associated with the index visit, the mean BMI values will be used), with ≥1 diagnosed obesity-associated chronic conditions at any time in any location in their baseline year (see
Outcome variables will include overall emergency department visits and overall hospitalizations. These are 2 of the 4 primary outcomes for outpatient continuity of care association with health care use; the effect of geographic, income, ethnic, and racial disparities; and continuity of care protective effects; and are secondary outcomes for characteristics of health care systems with high continuity of care and low utilization. Hospitalizations will include observations visits, and emergency department visits resulting in observation or inpatient visits on the same or following day will be counted as hospitalizations.
Preventable emergency department visits and preventable hospitalizations will be defined by The Agency for Healthcare Research and Quality Prevention Quality Indicators chronic composite measures and will be identified using the primary diagnosis for diabetes short-term complications, diabetes long-term complications, chronic obstructive pulmonary disease or asthma in older adults, hypertension, angina without procedure, uncontrolled diabetes, asthma in younger adults, and lower extremity amputation among patients with diabetes [
[
A
Percentage of total providers with primary care specialty (number unique primary care providers / total unique providers), using “ProviderID” and “Provider_Specialty_Primary” labels from practice-based research networks data or, if necessary, using health system provider records.
Percentage of total encounters in ambulatory setting (number of ambulatory encounters / number of ambulatory + hospital encounters) in the practice-based research networks.
Ambulatory site geographic density (number of ambulatory sites per square mile for all unique ZIP codes with one or more health system ambulatory sites or inpatient facilities). We will use the “Facility_Location” label to assess ZIP codes for clinic sites, or if necessary, health system records.
Other covariates such as sociodemographic factors will be assessed at the index visit or the first visit in the baseline year for which data is available and will include age (continuous), gender (male, female), and race (Black or African-American, White, other). Clinical factors will include Charlson comorbidity index [
The main analysis will be conducted among patients with obesity-associated chronic conditions. Multivariable negative binomial models will be used to model overall and preventable hospitalizations and emergency department visits. For continuity of care as an outcome, a fractional regression model will be used. Interaction terms between (1) continuity of care and patient residence health professional shortage area designation, (2) continuity of care and patient residence low income status, and (3) continuity of care and patient race will be included to examine whether the association between continuity and health care utilization varies by these factors. The same will be assessed in patients with type 2 diabetes.
Finally, we will conduct a distributed meta-analysis using direct aggregate data from each site following the method employed by Toh [
This study protocol has been approved by the Institutional Review Board of the 4 sponsoring institutions (University of Tennessee Health Science Center protocol 18-06394-XP, Tulane Medical Center protocol 2018-2306, University of Mississippi Medical Center protocol 2019-0005, Ochsner Health System protocol 2019.035). The findings of this study will be submitted as manuscripts to peer-reviewed journals to aid dissemination to policy makers and other researchers in the field. It will also be presented and discussed at Annual Delta Clinical and Translational Science Health Disparities Conference.
Each site is currently analyzing data, reporting, and submitting the aggregate results; 4 regional health systems across the southern United States have completed collection of data sets and data management at each site.
Southern Obesity and Diabetes Coalition practice-based research network locations and characteristics.
Sponsoring institution | City and state | Geographic coverage | Adult hospitals, n | Outpatient practices, n | Unique adult patients served, n |
Ochsner Health System | Jefferson, Louisiana | Southeast Louisiana including the Greater New Orleans area, Slidell, Covington, Raceland, and Baton Rouge | 40 | >100 | 1,374,751 |
Tulane Medical Center | New Orleans, Louisiana | Greater New Orleans area | 4 | 34 | 25,709 |
University of Mississippi Medical Center | Jackson, Mississippi | Mississippi | 4 | 255 | 361,288 |
University of Tennessee Health Science Center | Memphis, Tennessee | West Tennessee, Arkansas, Mississippi | 5 | 60 | 394,112 |
The 4 health systems and their respective practice-based research networks include patients across 4 southern states, including Arkansas, Louisiana, Mississippi, and Tennessee, with among the highest obesity prevalence in the United States at 37.1%, 36.8%, 39.5% and 34.4%, respectively [
Our research employs an innovative method—inverse variance-weighted meta-analysis across distributed data networks—as employed by the FDA minisentinel program and others [
The study is subject to some limitations. Although we standardized data attributes to the best of our ability, there were still a few variables that were not consistently reported across the sites. As a result, we were unable to assess insurance status, provider-level continuity of care, primary-care continuity of care, and specialty-care continuity of care due to lack of consistent information. The study is also limited by inconsistencies in data collection practices among participating providers. For example, the income and race or ethnicity information were not consistently collected for subset populations across health systems.
This study employs an innovative collaborative research approach and has potential to yield important actionable results that can be employed to improve health care delivery for the vulnerable populations with obesity-associated chronic conditions and with type 2 diabetes. The Southern Obesity and Diabetes Coalition’s use of a cooperative meta-analysis method provides a way for researchers to gain the economies of scale needed to answer important pragmatic health services research questions. Furthermore, the worldwide pandemic of obesity and obesity-associated chronic conditions makes this research particularly relevant.
Obesity-associated chronic conditions qualifying diagnosis codes (ICD-9 and ICD-10).
Food and Drug Administration
International Classification of Diseases
None declared.